insider
NYSE · BSX
Boston Scientific Corporation
Healthcare · Medical - Devices
$43.87
Down-$1.18 (-2.62%)
Updated Sep 16, 2026, 12:12 PM
SID Score
4.9/10
Composite research score
Smart Money
74/100
Bullish
- Market cap
- 135.98B
- P/E ratio
- 48.75
- Dividend yield
- 0.00%
- 52-week range
- $42.20 – $100.90
- Volume
- 16.02M
- Avg. volume
- 9.87M
Price performance
BSX price history
1M range · 20 trading sessions · Daily adjusted prices
BSX closed at $43.87 after 20 trading sessions, down 13.08% for the selected period.
- Last close
- $43.87
- Period change
- -13.08%
- Period low
- $42.98
- Period high
- $52.01
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $44.32 | $44.9889 | $43.68 | $43.87 | 16.02M |
| Sep 14, 2026 | $44.00 | $45.15 | $43.85 | $45.05 | 20.52M |
| Sep 11, 2026 | $43.19 | $43.55 | $42.795 | $42.98 | 26.99M |
| Sep 10, 2026 | $44.13 | $44.42 | $42.78 | $43.10 | 22.69M |
| Sep 9, 2026 | $45.105 | $46.265 | $44.89 | $44.96 | 17.98M |
| Sep 8, 2026 | $47.43 | $47.45 | $44.85 | $44.98 | 29.03M |
| Sep 4, 2026 | $46.92 | $48.0583 | $46.83 | $47.80 | 15.5M |
| Sep 3, 2026 | $48.58 | $49.2656 | $46.80 | $46.95 | 19.73M |
| Sep 2, 2026 | $47.91 | $49.66 | $47.91 | $48.37 | 17.02M |
| Sep 1, 2026 | $49.115 | $49.115 | $47.27 | $48.08 | 12M |
| Aug 31, 2026 | $46.40 | $48.965 | $46.09 | $48.30 | 18.91M |
| Aug 28, 2026 | $46.85 | $47.22 | $46.50 | $46.84 | 17.15M |
| Aug 27, 2026 | $48.00 | $48.07 | $46.61 | $46.67 | 16.28M |
| Aug 26, 2026 | $47.00 | $48.54 | $46.90 | $48.17 | 36.58M |
| Aug 25, 2026 | $48.79 | $50.04 | $48.54 | $49.86 | 17.37M |
| Aug 24, 2026 | $50.29 | $50.38 | $48.77 | $49.01 | 22.03M |
| Aug 21, 2026 | $49.22 | $50.90 | $49.01 | $50.37 | 35.99M |
| Aug 20, 2026 | $51.64 | $51.80 | $49.36 | $49.37 | 20.39M |
| Aug 19, 2026 | $50.80 | $52.56 | $50.66 | $52.01 | 16.83M |
| Aug 18, 2026 | $52.38 | $52.53 | $50.45 | $50.47 | 11.72M |
Latest BSX news
The latest Smart Investors Daily articles mentioning BSX.
Stock researchResearch & News · Analysis
Loading stock research…